Takeda Canada Inc. ("Takeda") announces new data highlighting the impact Inflammatory Bowel Disease (IBD) has on Canadians. The data reveals insights into how the disease affects daily life, the ...

Nordic Bioscience, a leading biomarker company, announced that its CPa9-HNE biomarker assay received a Letter of Support (LoS ...

Werewolf Therapeutics, Inc. (the“Company” or“Werewolf”) (Nasdaq: HOWL), an innovative biopharmaceutical company pioneering the development of conditionally activated therapeutics engineered to ...

Global poultry vaccine market is observing significant growth owing to the rising prevalence of poultry diseases. The report runs an in-dept ...

According to IBD Stock Checkup, the stock has seen four ... GoDaddy says GoDaddy Airo enables users to create logos in minutes, as well as tap AI to get websites ready in seconds.

The study identifies links between gut microbiota, genetic variants in IBD, and mental health disorders, offering insights ...

Aeglea Biotherapeutics Inc. ( (SYRE) ) has released its Q3 earnings. Here is a breakdown of the information Aeglea Biotherapeutics Inc.

Not everyone responds equally well to treatments for inflammatory bowel disease (IBD). What will work for individual patients involves trial and error during the treatment process.

Vertiv stock shares have risen 175% as of November 11. Last month, the data center hardware and services provider exceeded ...

The company also reported progress in its NLRP3 and IBD portfolios, emphasizing potential best-in-class profiles for its candidates. Despite some setbacks, such as the VTX958 trial in Crohn’s disease, ...

Sydney Towle is sharing her cancer journey on social media as a way to connect with and help others. She's currently waiting for a new treatment plan.